BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15649144)

  • 1. Aggregation and fibrillization of prions in lipid membranes.
    Kazlauskaite J; Pinheiro TJ
    Biochem Soc Symp; 2005; (72):211-22. PubMed ID: 15649144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prion protein and lipid rafts.
    Taylor DR; Hooper NM
    Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of lipid rafts in prion protein biology.
    Lewis V; Hooper NM
    Front Biosci (Landmark Ed); 2011 Jan; 16(1):151-68. PubMed ID: 21196164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glypican-1 mediates both prion protein lipid raft association and disease isoform formation.
    Taylor DR; Whitehouse IJ; Hooper NM
    PLoS Pathog; 2009 Nov; 5(11):e1000666. PubMed ID: 19936054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein aggregation and fibrillogenesis in vitro.
    Stöhr J
    Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.
    Bate C; Nolan W; Williams A
    J Biol Chem; 2016 Jan; 291(1):160-70. PubMed ID: 26553874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of antisera to purified prions in lipid rafts.
    Hnasko R; Serban AV; Carlson G; Prusiner SB; Stanker LH
    Prion; 2010; 4(2):94-104. PubMed ID: 20647769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transmembrane form of the prion protein in neurodegenerative disease.
    Hegde RS; Mastrianni JA; Scott MR; DeFea KA; Tremblay P; Torchia M; DeArmond SJ; Prusiner SB; Lingappa VR
    Science; 1998 Feb; 279(5352):827-34. PubMed ID: 9452375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of prion proteins to lipid membranes.
    Critchley P; Kazlauskaite J; Eason R; Pinheiro TJ
    Biochem Biophys Res Commun; 2004 Jan; 313(3):559-67. PubMed ID: 14697227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
    Surewicz WK; Jones EM; Apetri AC
    Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
    Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into prion structure and toxicity.
    Harris DA; True HL
    Neuron; 2006 May; 50(3):353-7. PubMed ID: 16675391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PrP interactions with nucleic acids and glycosaminoglycans in function and disease.
    Silva JL; Gomes MP; Vieira TC; Cordeiro Y
    Front Biosci (Landmark Ed); 2010 Jan; 15(1):132-50. PubMed ID: 20036811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the cellular prion protein with raft-like lipid membranes.
    Elfrink K; Nagel-Steger L; Riesner D
    Biol Chem; 2007 Jan; 388(1):79-89. PubMed ID: 17214553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation.
    Bate C; Tayebi M; Williams A
    J Biol Chem; 2010 Jul; 285(29):22017-26. PubMed ID: 20427265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.